Frantz EyeCare reports 98% of Light Adjustable Lens patients achieved refractive accuracy within ±0.50 D of target, exceeding published national cataract surgery benchmarks.
|Articles|October 12, 2016
Impactful Tips to Integrate the CATALYS® Precision Laser System
This presentation will provide an overview of how the CATALYS® Precision Laser System is engineered for outstanding clinical outcomes and allows the cataract surgeon to make their process efficient.
Advertisement
This presentation will provide an overview of how the CATALYS® Precision Laser System is engineered for outstanding clinical outcomes and allows the cataract surgeon to make their process efficient.
Learning Objectives:
- Identify core benefits for surgeons and patients from the purchase of a femtosecond laser system.
- Select appropriate messaging to include in patient education materials that explain the benefits of a femtosecond laser.
- Discuss ways in which the introduction of the CATALYS® Laser System impacts day-to-day workflow in the surgical setting.
- Describe the broad range of cataract cases in which the CATALYS® Laser System can be used successfully to optimize patient outcomes
Speaker:
Keith A. Walter, MD
Professor, Ophthalmology
Wake Forest Baptist Medical Center
Winston-Salem, NC
Advertisement
Related to this article
In this Q&A, Ping Moore, OD, covers emerging dry eye therapies, from selenium sulfide to next-gen cyclosporine, and how subtype-guided care shapes treatment choices.
Ophthalmology is projected to face one of the steepest physician shortages of any subspecialty by 2038.
Two investigational pipeline therapies take aim at the root causes of dry eye disease
Dry eye care pivots to root-cause diagnosis and personalized biologics/devices,
Cataract surgery becomes refractive: learn how IOL choices and preop counseling across distance, intermediate and near turn 20/20 into 20/happy.
Findings from the third annual State of Dry Eye survey link symptom management to quality of life gains, including lower anxiety and improved self-confidence.
June brings FDA clearance for Lumvoa, key retina and glaucoma trials, device deals, and hard truths on AI performance in eye care.
Advertisement
Advertisement